⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 6, 2024Open Access

Supplementary Figure S8 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency

Aditya Kulkarni Jianli Zhou Neha Biyani Umesh Kathad Partha P. Banerjee Shiv Srivastava Zsombor Prucsi Kamil Solarczyk Kishor Bhatia Reginald B. Ewesuedo Panna Sharma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Figure S8 shows mouse body weight changes in selected TNBC PDX models following LP-184 treatment

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kulkarni et al. (2024) studied this question.

synapsesocial.com/papers/68e6b5fbb6db643587637747 https://doi.org/10.1158/2767-9764.25757513.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S8 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
2Supplementary Figure S7 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
3Supplementary Figure S7 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
4Supplementary Figure S9 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
5Supplementary Figure S9 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024

Supplementary Figure S10 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
Supplementary Figure S10 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
Supplementary Figure S4 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024